The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients

被引:39
|
作者
Papadimitriou-Olivgeris, M. [1 ]
Christofidou, M. [2 ]
Fligou, F. [3 ]
Bartzavali, C. [2 ]
Vrettos, T. [3 ]
Filos, K. S. [3 ]
Marangos, M. [1 ]
Anastassiou, E. D. [2 ]
机构
[1] Univ Patras, Sch Med, Div Infect Dis, Rion 26504, Greece
[2] Univ Patras, Sch Med, Dept Microbiol, Rion 26504, Greece
[3] Univ Patras, Sch Med, Rion 26504, Greece
关键词
Carriage; Resistance epidemiology; Surveillance; Intensive Care Unit; Carbapenemase; INTENSIVE-CARE-UNIT; ENTERIC COLONIZATION; BETA-LACTAMASES; RISK-FACTORS; INFECTIONS; EMERGENCE; GREECE; ENTEROBACTERIACEAE; DECONTAMINATION; CARBAPENEMASES;
D O I
10.1007/s15010-014-0653-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To identify the risk factors for incident enteric colonization by KPC-producing Klebsiella pneumoniae (KPC-Kp) resistant to colistin or tigecycline during Intensive Care Unit (ICU) stay. A prospective observational study of patients admitted to the ICU was conducted during a 27-month period. Rectal samples taken upon admission and weekly afterwards were inoculated on selective chromogenic agar. K. pneumoniae isolates were characterized by standard methodology. Mean inhibitory concentration (MIC) to colistin and tigecycline were determined by E-test. The presence of bla (KPC) gene was confirmed by PCR. Among 254 patients, 62 (24.4 %) became colonized by colistin- resistant KPC-Kp during their stay. Multivariate analysis revealed that corticosteroid, colistin administration and number of colonized patients in nearby beds per day were significantly associated with colonization. Among 257 patients, 39 (17.9 %) became colonized by tigecycline resistant KPC-Kp during their stay. Risk factors identified by multivariate analysis were: days at risk, obesity, number of colonized patients treated in nearby beds per day and administration of tigecycline. The high prevalence of colistin or tigecycline resistant KPC-Kp enteric carriage in ICU patients indicate that dissemination is due to their transfer from patient to patient via the personnel and indicates the importance of strict infection control protocols.
引用
收藏
页码:883 / 890
页数:8
相关论文
共 50 条
  • [41] KPC-Producing, Multidrug-Resistant Klebsiella pneumoniae Sequence Type 258 as a Typical Opportunistic Pathogen
    Tzouvelekis, L. S.
    Miriagou, V.
    Kotsakis, S. D.
    Spyridopoulou, K.
    Athanasiou, E.
    Karagouni, E.
    Tzelepi, E.
    Daikos, G. L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (10) : 5144 - 5146
  • [42] Synergistic effect of fosfomycin and colistin against KPC-producing Klebsiella pneumoniae: pharmacokinetics-pharmacodynamics combined with transcriptomic approach
    Zhang, Jiajie
    Xu, Liqian
    Zhang, Kanghui
    Yue, Junpeng
    Dong, Kaixuan
    Luo, Qixia
    Yu, Wei
    Huang, Yicheng
    BMC MICROBIOLOGY, 2024, 24 (01):
  • [43] Colistin-Resistant, Klebsiella pneumoniae Carbapenemase (KPC)-Producing Klebsiella pneumoniae Belonging to the International Epidemic Clone ST258
    Bogdanovich, Tatiana
    Adams-Haduch, Jennifer M.
    Tian, Guo-Bao
    Minh Hong Nguyen
    Kwak, Eun Jeong
    Muto, Carlene A.
    Doi, Yohei
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (04) : 373 - 376
  • [44] Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization
    Gaibani, P.
    Re, M. C.
    Campoli, C.
    Viale, P. L.
    Ambretti, S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (04) : 516.e1 - 516.e4
  • [45] Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae
    Ceccarelli, Giancarlo
    Falcone, Marco
    Giordano, Alessandra
    Mezzatesta, Maria Lina
    Caio, Carla
    Stefani, Stefania
    Venditti, Mario
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) : 2900 - 2901
  • [46] Emergence of Colistin Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Under the Pressure of Tigecycline
    Zhang, Yawei
    Wang, Xiaojuan
    Wang, Shifu
    Sun, Shijun
    Li, Henan
    Chen, Hongbin
    Wang, Qi
    Wang, Hui
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [47] In Vivo Evolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin Treatment
    Cannatelli, Antonio
    Di Pilato, Vincenzo
    Giani, Tommaso
    Arena, Fabio
    Ambretti, Simone
    Gaibani, Paolo
    D'Andrea, Marco Maria
    Rossolini, Gian Maria
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (08) : 4399 - 4403
  • [48] Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period
    Papadimitriou-Olivgeris, Matthaios
    Bartzavali, Christina
    Spyropoulou, Aikaterini
    Lambropoulou, Anastasia
    Sioulas, Nektarios
    Vamvakopoulou, Sophia
    Karpetas, Georgios
    Spiliopoulou, Iris
    Vrettos, Theofanis
    Anastassiou, Evangelos D.
    Fligou, Fotini
    Christofidou, Myrto
    Marangos, Markos
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 92 (03) : 235 - 240
  • [49] Comparison of Polymyxin B, Tigecycline, Cefepime, and Meropenem MICs for KPC-Producing Klebsiella pneumoniae by Broth Microdilution, Vitek 2, and Etest
    Lat, Asma
    Clock, Sarah A.
    Wu, Fann
    Whittier, Susan
    Della-Latta, Phyllis
    Fauntleroy, Kathy
    Jenkins, Stephen G.
    Saiman, Lisa
    Kubin, Christine J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (05) : 1795 - 1798
  • [50] Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing Klebsiella pneumoniae during tigecycline treatment
    He, Fang
    Shi, Qiucheng
    Fu, Ying
    Xu, Juan
    Yu, Yunsong
    Du, Xiaoxing
    INFECTION GENETICS AND EVOLUTION, 2018, 66 : 188 - 191